Clinical Trial Update: Neoadjuvant Atezolizumab in Cutaneous Melanoma [Phase 1]

View source ↗

Summary

Phase 1 neoadjuvant trial of atezolizumab in patients with cutaneous melanoma; the study is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Cutaneous Melanoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING